BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 31059675)

  • 21. Human T-cell lymphotropic virus type I (HTLV-I) proviral DNA viral load among asymptomatic patients and patients with HTLV-I-associated myelopathy/tropical spastic paraparesis.
    Montanheiro PA; Oliveira AC; Posada-Vergara MP; Milagres AC; Tauil C; Marchiori PE; Duarte AJ; Casseb J
    Braz J Med Biol Res; 2005 Nov; 38(11):1643-7. PubMed ID: 16258633
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dermatological findings in 3 generations of a family with a high prevalence of human T cell lymphotropic virus type 1 infection in Brazil.
    Nobre V; Guedes AC; Martins ML; Barbosa-Stancioli EF; Serufo JC; Proietti FA; Ribas JG; Ferreira CE; Lambertucci JR;
    Clin Infect Dis; 2006 Nov; 43(10):1257-63. PubMed ID: 17051489
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Temporal dynamics of human T-lymphotropic virus type I tax mRNA and proviral DNA load in peripheral blood mononuclear cells of human T-lymphotropic virus type I-associated myelopathy patients.
    Ramirez E; Cartier L; Torres M; Barria M
    J Med Virol; 2007 Jun; 79(6):782-90. PubMed ID: 17457906
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bronchoalveolar lymphocytosis correlates with human T lymphotropic virus type I (HTLV-I) proviral DNA load in HTLV-I carriers.
    Mori S; Mizoguchi A; Kawabata M; Fukunaga H; Usuku K; Maruyama I; Osame M
    Thorax; 2005 Feb; 60(2):138-43. PubMed ID: 15681503
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence and risk factors for Human T-Lymphotropic Virus Type 1 (HTLV-1) among maintenance hemodialysis patients.
    Santos RF; Conceição GC; Martins MS; Kraychete A; Penalva MA; Carvalho EM; Lopes AA; Rocha PN
    BMC Nephrol; 2017 Feb; 18(1):64. PubMed ID: 28202003
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human T-cell leukemia virus type 1 infection among Japanese immigrants and their descendants living in Southeast Brazil: A call for preventive and control responses.
    Bandeira LM; Puga MAM; Weis-Torres SMS; Rezende GR; Domingos JA; Tanaka TSO; Cesar GA; Nukui Y; Vicente ACP; Casseb J; Yamashiro J; Segurado AC; Saito MO; Pinho JRR; Cunha RV; Okumoto O; Uehara SNO; Motta-Castro ARC
    PLoS Negl Trop Dis; 2021 Feb; 15(2):e0009066. PubMed ID: 33544713
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Usefulness of proviral load measurement for monitoring of disease activity in individual patients with human T-lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis.
    Takenouchi N; Yamano Y; Usuku K; Osame M; Izumo S
    J Neurovirol; 2003 Feb; 9(1):29-35. PubMed ID: 12587066
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitation of HTLV-I and II proviral load using real-time quantitative PCR with SYBR Green chemistry.
    Lee TH; Chafets DM; Busch MP; Murphy EL
    J Clin Virol; 2004 Dec; 31(4):275-82. PubMed ID: 15494269
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo proviral burden and viral RNA expression in T cell subsets of patients with human T lymphotropic virus type-1-associated myelopathy/tropical spastic paraparesis.
    Cho I; Sugimoto M; Mita S; Tokunaga M; Imamura F; Ando M
    Am J Trop Med Hyg; 1995 Oct; 53(4):412-8. PubMed ID: 7485696
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estimation of the infectious viral load required for transfusion-transmitted human T-lymphotropic virus type 1 infection (TT-HTLV-1) and of the effectiveness of leukocyte reduction in preventing TT-HTLV-1.
    Sobata R; Matsumoto C; Uchida S; Suzuki Y; Satake M; Tadokoro K
    Vox Sang; 2015 Aug; 109(2):122-8. PubMed ID: 25930000
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human T Cell Leukemia Virus Type 1 and Eye Diseases.
    Terada Y; Kamoi K; Komizo T; Miyata K; Mochizuki M
    J Ocul Pharmacol Ther; 2017 May; 33(4):216-223. PubMed ID: 28263674
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Presence of tropical spastic paraparesis/human T-cell lymphotropic virus type 1-associated myelopathy (TSP/HAM)-like among HIV-1-infected patients.
    Casseb J; de Oliveira AC; Vergara MP; Montanheiro P; Bonasser F; Meilman Ferreira C; Smid J; Duarte AJ
    J Med Virol; 2008 Mar; 80(3):392-8. PubMed ID: 18205234
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human T lymphotropic virus type 1 (HTLV-1) proviral load in asymptomatic carriers, HTLV-1-associated myelopathy/tropical spastic paraparesis, and other neurological abnormalities associated with HTLV-1 infection.
    Silva MT; Harab RC; Leite AC; Schor D; Araújo A; Andrada-Serpa MJ
    Clin Infect Dis; 2007 Mar; 44(5):689-92. PubMed ID: 17278060
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of depression on quality of life in people living with human T cell lymphotropic virus type 1 (HTLV-1) in Salvador, Brazil.
    Galvão-Castro AV; Boa-Sorte N; Kruschewsky RA; Grassi MF; Galvão-Castro B
    Qual Life Res; 2012 Nov; 21(9):1545-50. PubMed ID: 22109110
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased HTLV-I proviral DNA in HTLV-I-associated myelopathy: a quantitative polymerase chain reaction study.
    Kira J; Koyanagi Y; Yamada T; Itoyama Y; Goto I; Yamamoto N; Sasaki H; Sakaki Y
    Ann Neurol; 1991 Feb; 29(2):194-201. PubMed ID: 2012389
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human T cell lymphotropic virus type 1 viral load variability and long-term trends in asymptomatic carriers and in patients with human T cell lymphotropic virus type 1-related diseases.
    Demontis MA; Hilburn S; Taylor GP
    AIDS Res Hum Retroviruses; 2013 Feb; 29(2):359-64. PubMed ID: 22894552
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of Sicca Syndrome with Proviral Load and Proinflammatory Cytokines in HTLV-1 Infection.
    Lima CM; Santos S; Dourado A; Carvalho NB; Bittencourt V; Lessa MM; Siqueira I; Carvalho EM
    J Immunol Res; 2016; 2016():8402059. PubMed ID: 26904697
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Keratoconjunctivitis sicca and chronic HCV infection.
    Siagris D; Pharmakakis N; Christofidou M; Petropoulos JK; Vantzou C; Lekkou A; Gogos CA; Labropoulou-Karatza C
    Infection; 2002 Aug; 30(4):229-33. PubMed ID: 12236567
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lack of association between single-nucleotide polymorphisms of pro- and anti-inflammatory cytokines and HTLV-1-associated myelopathy / tropical spastic paraparesis development in patients from Rio de Janeiro, Brazil.
    Schor D; Porto LC; Roma EH; Quintana MSB; Fabricio-Silva GM; Bonecini-Almeida MG; Araújo AQ; Andrada-Serpa MJ
    BMC Infect Dis; 2018 Nov; 18(1):593. PubMed ID: 30466392
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM/TSP.
    Nagai M; Usuku K; Matsumoto W; Kodama D; Takenouchi N; Moritoyo T; Hashiguchi S; Ichinose M; Bangham CR; Izumo S; Osame M
    J Neurovirol; 1998 Dec; 4(6):586-93. PubMed ID: 10065900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.